English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18268/20495 (89%)
Visitors : 8433733      Online Users : 489
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34637


    標題: Oroxylin-A and its phosphonate derivative potentiate eNOS/NO-mediated relaxation and attenuate vasoconstrictor-induced contraction in the mouse aorta
    作者: Tseng, Tzu-Ling
    Ho, Wen-Yueh
    Huang, Po-Jui
    Liao, Jin-Zhi
    Lee, Kuan-Han
    貢獻者: Buddhist Tzu Chi General Hospital
    Hualien Tzu Chi Hospital
    Tzu Chi University of Science & Technology
    Chia Nan University of Pharmacy & Science
    Kaohsiung Medical University
    Department of Cosmetic Science, Chia Nan University of Pharmacy & Science
    Departments of Medicinal Chemistry, Chia Nan University of Pharmacy & Science
    Departmentof Pharmacy, Chia Nan University of Pharmacy & Science
    關鍵字: nitric-oxide
    memory impairment
    channels
    inhibition
    flavonoids
    日期: 2022
    上傳時間: 2023-12-11 14:01:55 (UTC+8)
    出版者: JAPANESE PHARMACOLOGICAL SOC
    摘要: Oroxylin-A (OroA), a flavonoid isolated from Scutellariae baicalensis, alleviates cardiovascular dysfunction. Several procedures for synthesizing OroA have been developed but show low production yield and regioselectivity. We synthesized OroA from baicalin using a one-pot reaction to increase its overall yield. We also determined the chemical properties and mechanism of action of the synthesized OroA and OroA phosphate diethyl ester (OroA-OET) in vascular function. The induction of vascular reactivity by OroA and OroA-OET was evaluated using blood vessel myography and biochemical analysis to assess nitric oxide synthase-mediated nitric oxide production in mouse aortic arteries. OroA and OroA-OET (0.1-30 mM) induced sustained vasorelaxation, which was partly mediated by the endothelium in isolated normal arteries pre-contracted with phenylephrine. OroA and OroA-OET significantly attenuated vasoconstrictors-induced contractile responses. Dilation effects were blocked by the non-selective nitric oxide synthase inhibitor N (omega)-nitro-L-arginine methyl ester but not by tetraethylammonium or 1H(1,2,4)oxadiazolo [4,3-a]quinoxalin-1-one. Notably, preincubation with OroA and OroA-OET potentiated acetylcholine-induced relaxation and endothelial nitric oxide production in the arteries with the endothelium. OroA and OroA-OET protected against cardiovascular dysfunction. The synthesis and lead compounds used not only improved the yield of OroA from natural sources but also potentially regulated vascular tone.(c) 2022 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
    關聯: JOURNAL OF PHARMACOLOGICAL SCIENCES, v.150, Issue 4, pp.223-232
    Appears in Collections:[化妝品應用與管理系(所)] 期刊論文
    [藥學系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML305View/Open
    j.jphs.2022.09.007.pdf1875KbAdobe PDF151View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback